Skip to main content
Top
Published in: International Urology and Nephrology 2/2011

01-06-2011 | Urology – Original Paper

Atrophy in specimens of radical prostatectomy: is there topographic relation to high-grade prostatic intraepithelial neoplasia or cancer?

Authors: Antonio A. Brasil, Wagner J. Favaro, Valeria H. Cagnon, Ubirajara Ferreira, Athanase Billis

Published in: International Urology and Nephrology | Issue 2/2011

Login to get access

Abstract

Introduction

It is controversial whether there is any relationship of proliferative inflammatory atrophy (PIA) to high-grade prostatic intraepithelial neoplasia (HGPIN) and cancer (CA). It has been suggested a topographic relation and a potential of the proliferative epithelium in PIA to progress to HGPIN and/or CA. The aim of this study was to analyze in radical prostatectomies a possible topographic relation of the lesions.

Materials and methods

A total of 3,186 quadrants from 100 whole-mount consecutive surgical specimens were examined. The frequency of quadrants showing: only PIA, PIA+CA, PIA+HGPIN, or PIA+HGPIN+CA was determined. Extent and distance between the lesions were evaluated by a semiquantitative point-count method previously described. We also studied foci with partial or complete atrophy without inflammation. The statistical methods included the Kruskal–Wallis and the Mann–Whitney tests and the Spearman correlation coefficient.

Results

The mean (range) of quadrants showing only PIA, PIA+CA, PIA+HGPIN, and PIA+HGPIN+CA was 3.29 (0–21), 2.51 (0–11), 0.77 (0–6), and 0.44 (0–4), respectively (P < 0.01). Most of the foci of PIA were significantly located in a distance >5 than <5 mm from HGPIN or CA. There was no significant correlation between extent of PIA (P = 0.64, r = 0.05) with extent of HGPIN. There was a significant negative correlation of extent of PIA (P = 0.01, r = −0.27) with extent of CA. Similar results were found considering foci either with or without inflammation. Chronic inespecific inflammation was not seen in foci of partial atrophy.

Conclusion

A topographic relation of PIA to HGPIN and/or CA was not supported by our study.
Literature
1.
go back to reference Ames BN (1989) Mutagenesis and carcinogenesis: endogenous and exogenous factors. Environ Mol Mutagen 14:66–77PubMedCrossRef Ames BN (1989) Mutagenesis and carcinogenesis: endogenous and exogenous factors. Environ Mol Mutagen 14:66–77PubMedCrossRef
2.
go back to reference Weitzman SA, Gordon LI (1990) Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 76:655–663PubMed Weitzman SA, Gordon LI (1990) Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 76:655–663PubMed
3.
go back to reference Bartsch H, Frank N (1998) Blocking the endogenous formation of N-nitroso compounds and related carcinogens. IARC Sci Publ 139:189–201 Bartsch H, Frank N (1998) Blocking the endogenous formation of N-nitroso compounds and related carcinogens. IARC Sci Publ 139:189–201
4.
go back to reference Billis A (1998) Prostatic atrophy: an autopsy study of a histologic mimic of adenocarcinoma. Mod Pathol 11:47–54PubMed Billis A (1998) Prostatic atrophy: an autopsy study of a histologic mimic of adenocarcinoma. Mod Pathol 11:47–54PubMed
5.
go back to reference De Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999) Proliferative inflammatory atrophy of the prostate; implications for prostatic carcinogenesis. Am J Pathol 155:1985–1992PubMedCrossRef De Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999) Proliferative inflammatory atrophy of the prostate; implications for prostatic carcinogenesis. Am J Pathol 155:1985–1992PubMedCrossRef
6.
go back to reference Anton RC, Kattan MW, Chakraborty S, Wheeler TM (1999) Postatrophic hyperplasia of the prostate: lack of association with prostate cancer. Am J Surg Pathol 23:932–936PubMedCrossRef Anton RC, Kattan MW, Chakraborty S, Wheeler TM (1999) Postatrophic hyperplasia of the prostate: lack of association with prostate cancer. Am J Surg Pathol 23:932–936PubMedCrossRef
7.
go back to reference Putzi MJ, De Marzo AM (2000) Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 56:828–832PubMedCrossRef Putzi MJ, De Marzo AM (2000) Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 56:828–832PubMedCrossRef
8.
go back to reference Montironi R, Mazzucchelli R, Scarpelli M (2002) Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention. Ann NY Acad Sci 963:169–184PubMedCrossRef Montironi R, Mazzucchelli R, Scarpelli M (2002) Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention. Ann NY Acad Sci 963:169–184PubMedCrossRef
9.
go back to reference van Leenders GJ, Gage WR, Hicks JL, van Balken B, Aalders TW, Schalken JA et al (2003) Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol 162:1529–1537PubMedCrossRef van Leenders GJ, Gage WR, Hicks JL, van Balken B, Aalders TW, Schalken JA et al (2003) Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol 162:1529–1537PubMedCrossRef
10.
go back to reference De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA et al (2003) Human prostate cancer precursors and pathobiology. Urology 62:55–62PubMed De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA et al (2003) Human prostate cancer precursors and pathobiology. Urology 62:55–62PubMed
11.
go back to reference Billis A, Magna LA (2003) Inflammatory atrophy of the prostate. Prevalence and significance. Arch Pathol Lab Med 127:840–844PubMed Billis A, Magna LA (2003) Inflammatory atrophy of the prostate. Prevalence and significance. Arch Pathol Lab Med 127:840–844PubMed
12.
go back to reference Postma R, Schröder FH, van der Kwast TH (2005) Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology 65:745–749PubMedCrossRef Postma R, Schröder FH, van der Kwast TH (2005) Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology 65:745–749PubMedCrossRef
13.
go back to reference Billis A, Freitas LLL, Magna LA, Ferreira U (2007) Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer? Int Braz J Urol 33:355–360PubMedCrossRef Billis A, Freitas LLL, Magna LA, Ferreira U (2007) Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer? Int Braz J Urol 33:355–360PubMedCrossRef
14.
go back to reference Wang W, Bergh A, Damber JE (2009) Morphological transitions of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 69:1378–1386PubMedCrossRef Wang W, Bergh A, Damber JE (2009) Morphological transitions of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 69:1378–1386PubMedCrossRef
15.
go back to reference Oppenheimer JR, Wills ML, Epstein JI (1998) Partial atrophy in prostate needle cores: another diagnostic pitfall for the surgical pathologist. Am J Surg Pathol 22:440–445PubMedCrossRef Oppenheimer JR, Wills ML, Epstein JI (1998) Partial atrophy in prostate needle cores: another diagnostic pitfall for the surgical pathologist. Am J Surg Pathol 22:440–445PubMedCrossRef
16.
go back to reference Billis A, Freitas LLL, Magna LA, Samara AB, Ferreira U (2004) Prostate cancer with bladder neck involvement: pathologic findings with application of a new practical method for tumor extent evaluation and recurrence-free survival after radical prostatectomy. Int Urol Nephrol 36:363–368PubMedCrossRef Billis A, Freitas LLL, Magna LA, Samara AB, Ferreira U (2004) Prostate cancer with bladder neck involvement: pathologic findings with application of a new practical method for tumor extent evaluation and recurrence-free survival after radical prostatectomy. Int Urol Nephrol 36:363–368PubMedCrossRef
17.
go back to reference Billis A, Meirelles L, Freitas LeandroLL (2010) Mergence of partial and complete atrophy in prostate needle biopsies: a morphologic and immunohistochemical study. Virchow Arch 456:689–694CrossRef Billis A, Meirelles L, Freitas LeandroLL (2010) Mergence of partial and complete atrophy in prostate needle biopsies: a morphologic and immunohistochemical study. Virchow Arch 456:689–694CrossRef
18.
go back to reference Przybycin CG, Kunju LP, Wu AJ, Shah RB (2008) Partial atrophy in prostate needle biopsies: a detailed analysis of its morphology, immunophenotype, and cellular kinetics. Am J Surg Pathol 32:58–64PubMedCrossRef Przybycin CG, Kunju LP, Wu AJ, Shah RB (2008) Partial atrophy in prostate needle biopsies: a detailed analysis of its morphology, immunophenotype, and cellular kinetics. Am J Surg Pathol 32:58–64PubMedCrossRef
19.
go back to reference Mikuz G, Algaba F, Beltran AL, Montironi R (2007) Prostate carcinoma: atrophy or not atrophy that is the question. Eur Urol 52:1293–1296PubMedCrossRef Mikuz G, Algaba F, Beltran AL, Montironi R (2007) Prostate carcinoma: atrophy or not atrophy that is the question. Eur Urol 52:1293–1296PubMedCrossRef
20.
go back to reference Tomas D, Kruslin B, Rogatsch H, Schäfer G, Belicza M, Mikuz G (2007) Different types of atrophy in the prostate with and without adenocarcinoma. Eur Urol 51:98–104PubMedCrossRef Tomas D, Kruslin B, Rogatsch H, Schäfer G, Belicza M, Mikuz G (2007) Different types of atrophy in the prostate with and without adenocarcinoma. Eur Urol 51:98–104PubMedCrossRef
Metadata
Title
Atrophy in specimens of radical prostatectomy: is there topographic relation to high-grade prostatic intraepithelial neoplasia or cancer?
Authors
Antonio A. Brasil
Wagner J. Favaro
Valeria H. Cagnon
Ubirajara Ferreira
Athanase Billis
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2011
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-010-9803-y

Other articles of this Issue 2/2011

International Urology and Nephrology 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.